NYSE:TAK
Takeda Pharmaceutical Company Limited
- Stock
Last Close
14.19
28/03 20:00
Market Cap
45.81B
Beta: 0.68
Volume Today
1.48M
Avg: 2.34M
PE Ratio
18.10
PFCF: −50.39
Dividend Yield
0.01%
Payout:161.87%
Mar '13 | Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cost and expenses | 1.43T - | 1.55T 8.20% | 1.91T 22.85% | 1.68T 12.09% | 1.58T 5.99% | 1.53T 3.01% | 1.94T 26.70% | 3.19T 64.74% | 2.69T 15.74% | 3.11T 15.61% | 3.54T 13.80% | |
cost of revenue | 447.63B - | 490.26B 9.52% | 520.99B 6.27% | 535.40B 2.77% | 558.75B 4.36% | 495.92B 11.25% | 659.69B 33.02% | 1.09T 65.19% | 994.31B 8.76% | 1.11T 11.32% | 1.24T 12.40% | |
depreciation and amortization | 201.11B - | 215.74B 7.28% | 260.95B 20.95% | 197.38B 24.36% | 222.79B 12.87% | 182.13B 18.25% | 272.45B 49.59% | 587.49B 115.64% | 665.27B 13.24% | 591.49B 11.09% | 718.68B 21.50% | |
ebitda | 351.18B - | 405.31B 15.42% | 148.39B 63.39% | 349.85B 135.76% | 389.38B 11.30% | 431.26B 10.75% | 376.38B 12.72% | 687.90B 82.77% | 1.17T 70.74% | 1.05T 10.40% | 1.21T 14.91% | |
eps | 94.11 - | 67.55 28.22% | -92.69 237.22% | 51.13 155.16% | 73.58 43.91% | 119.68 62.65% | 56.75 52.58% | 14.21 74.96% | 120.36 747.01% | 73.57 38.88% | 102.15 38.85% | |
eps diluted | 94.09 - | 67.47 28.29% | -92.69 237.38% | 50.86 154.87% | 73.13 43.79% | 118.78 62.42% | 56.43 52.49% | 14.13 74.96% | 119.48 745.58% | 72.94 38.95% | 100.97 38.43% | |
general and administrative expenses | 811.62B - | |||||||||||
gross profit | 1.11T - | 1.20T 8.27% | 1.26T 4.61% | 1.27T 1.20% | 1.17T 7.76% | 1.27T 8.63% | 1.44T 12.78% | 2.20T 53.14% | 2.20T 0.09% | 2.46T 11.74% | 2.78T 13.05% | |
income before tax | 129.71B - | 158.85B 22.47% | -145.44B 191.56% | 120.54B 182.88% | 143.35B 18.92% | 217.21B 51.52% | 94.90B 56.31% | -60.75B 164.02% | 366.24B 702.82% | 302.57B 17.38% | 375.09B 23.97% | |
income tax expense | -3.88B - | 49.29B 1,370.41% | -2.40B 104.88% | 37.06B 1,642.20% | 27.83B 24.90% | 30.50B 9.57% | -14.12B 146.29% | -105.04B 644.04% | -9.94B 90.54% | 72.41B 828.71% | 58.05B 19.82% | |
interest expense | 3.32B - | 30.72B 824.47% | 32.88B 7.02% | 31.93B 2.88% | 23.25B 27.19% | 31.93B 37.32% | 48.16B 50.83% | 165.01B 242.63% | 248.63B 50.68% | 166.61B 32.99% | 169.70B 1.86% | |
interest income | 16.30B - | 49.30B 202.38% | 15.36B 68.85% | 21.64B 40.95% | 12.27B 43.29% | 39.54B 222.17% | 6.62B 83.26% | 27.83B 320.47% | 105.52B 279.15% | 23.70B 77.54% | 62.91B 165.46% | |
net income | 131.24B - | 106.66B 18.73% | -145.78B 236.68% | 80.17B 154.99% | 114.94B 43.38% | 186.89B 62.59% | 109.13B 41.61% | 44.24B 59.46% | 376.00B 749.90% | 230.06B 38.81% | 317.02B 37.80% | |
operating expenses | 987.13B - | 1.06T 7.60% | 1.39T 30.50% | 1.14T 17.67% | 1.02T 10.84% | 1.03T 1.51% | 1.28T 23.66% | 2.10T 64.51% | 1.69T 19.36% | 2.00T 18.12% | 2.29T 14.57% | |
operating income | 122.50B - | 139.27B 13.69% | -129.25B 192.81% | 130.83B 201.22% | 155.87B 19.14% | 241.79B 55.13% | 204.97B 15.23% | 100.41B 51.01% | 509.27B 407.20% | 460.84B 9.51% | 490.50B 6.44% | |
other expenses | 5.81B - | 720.59B 12,300.43% | 1.00T 39.33% | 795.22B 20.79% | 705.13B 11.33% | 707.38B 0.32% | 908.87B 28.48% | 643.90B 29.15% | 362.74B 43.67% | 588.87B 62.34% | 662.27B 12.46% | |
research and development expenses | 341.56B - | 382.10B 11.87% | 345.93B 9.47% | 312.30B 9.72% | 325.44B 4.21% | 368.30B 13.17% | 492.38B 33.69% | 455.83B 7.42% | 526.09B 15.41% | 633.33B 20.38% | ||
revenue | 1.56T - | 1.69T 8.63% | 1.78T 5.09% | 1.81T 1.66% | 1.73T 4.17% | 1.77T 2.22% | 2.10T 18.45% | 3.29T 56.93% | 3.20T 2.84% | 3.57T 11.61% | 4.03T 12.85% | |
selling and marketing expenses | 175.52B - | |||||||||||
selling general and administrative expenses | 987.13B - | 556.21B 43.65% | 612.61B 10.14% | 650.77B 6.23% | 619.06B 4.87% | 628.11B 1.46% | 717.60B 14.25% | 964.74B 34.44% | 875.66B 9.23% | 886.36B 1.22% | 997.31B 12.52% | |
total other income expenses net | 7.20B - | 1B 86.11% | 1.34B 33.70% | -3M 100.22% | -1.55B 51,433.33% | -32.20B 1,982.73% | -4.51B 85.99% | -161.16B 3,473.44% | -143.03B 11.25% | -158.27B 10.65% | -115.42B 27.08% | |
weighted average shs out | 1.58B - | 1.58B 0.00% | 1.57B 0.39% | 1.57B 0.31% | 1.56B 0.36% | 1.56B 0.04% | 1.92B 23.14% | 3.11B 61.96% | 3.12B 0.31% | 3.13B 0.10% | 3.10B 0.75% | |
weighted average shs out dil | 1.58B - | 1.58B 0.09% | 1.57B 0.50% | 1.58B 0.23% | 1.57B 0.29% | 1.57B 0.10% | 1.93B 22.90% | 3.13B 61.98% | 3.15B 0.47% | 3.15B 0.23% | 3.14B 0.46% |
All numbers in USD (except ratios and percentages)